Published in Cancer Res on March 16, 2010
A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. PLoS Genet (2011) 1.49
LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-catenin. J Cancer Res Clin Oncol (2014) 0.83
LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells. Oncogene (2015) 0.83
KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes. Chem Biol (2015) 0.81
Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling. Blood Cancer J (2013) 0.79
LZTFL1 Upregulated by All-Trans Retinoic Acid during CD4+ T Cell Activation Enhances IL-5 Production. J Immunol (2015) 0.75
Depletion of BBS Protein LZTFL1 Affects Growth and Causes Retinal Degeneration in Mice. J Genet Genomics (2016) 0.75
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem (1991) 16.18
Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut (1987) 6.61
E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev (2009) 3.95
Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene (2008) 3.63
Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene (2007) 1.86
Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta (2006) 1.61
Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene (2003) 1.59
Wnt, stem cells and cancer in the intestine. Biol Cell (2005) 1.53
3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol (2005) 1.42
Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine). Semin Oncol (2005) 1.42
Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. Cancer Lett (2009) 1.29
DNA methylation patterns in lung carcinomas. Semin Cancer Biol (2009) 1.25
Epigenetics in human melanoma. Cancer Control (2009) 1.09
Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci (1999) 1.05
The LZTFL1 gene is a part of a transcriptional map covering 250 kb within the common eliminated region 1 (C3CER1) in 3p21.3. Genomics (2001) 0.94
Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells. Exp Cell Res (2006) 0.80
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res (2010) 2.54
Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell (2002) 2.53
A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell (2010) 2.40
Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep (2012) 2.37
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med (2006) 2.16
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol (2006) 2.02
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.73
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res (2002) 1.61
NOA: a novel Network Ontology Analysis method. Nucleic Acids Res (2011) 1.60
IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain (2007) 1.59
Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique. Circulation (2005) 1.57
Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. Mol Cancer Res (2013) 1.57
Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol (2008) 1.48
Involvement of opioid receptors in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation. Brain Res (2004) 1.47
Inferring gene regulatory networks from gene expression data by path consistency algorithm based on conditional mutual information. Bioinformatics (2011) 1.45
ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas. Anticancer Res (2008) 1.43
Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. J Mol Cell Biol (2012) 1.43
Early diagnosis and rescue pericardiocentesis for acute cardiac tamponade during radiofrequency ablation for arrhythmias. Is fluoroscopy enough? Pacing Clin Electrophysiol (2010) 1.41
Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain (2005) 1.37
Lung cancer cell lines: Useless artifacts or invaluable tools for medical science? Lung Cancer (2010) 1.30
Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment. Neoplasia (2009) 1.27
Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol (2005) 1.25
Activation of necroptosis in multiple sclerosis. Cell Rep (2015) 1.21
FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol Cell Biol (2007) 1.21
Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. Nat Rev Cancer (2014) 1.20
Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. Antimicrob Agents Chemother (2002) 1.20
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res (2006) 1.19
Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. Cancer Res (2003) 1.19
Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep (2012) 1.17
FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. J Biol Chem (2009) 1.15
RARα2 expression confers myeloma stem cell features. Blood (2013) 1.15
Organic/Organic' heterojunctions: organic light emitting diodes and organic photovoltaic devices. Macromol Rapid Commun (2009) 1.15
The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest (2011) 1.13
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Res (2010) 1.13
Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum (2003) 1.13
Efficient binomial leap method for simulating chemical kinetics. J Chem Phys (2007) 1.12
FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. Gastroenterology (2009) 1.11
An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer. J Am Med Inform Assoc (2012) 1.10
Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun (2008) 1.09
Identifying dysregulated pathways in cancers from pathway interaction networks. BMC Bioinformatics (2012) 1.09
Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. Am J Physiol Renal Physiol (2009) 1.09
Electroacupuncture attenuates bone cancer pain and inhibits spinal interleukin-1 beta expression in a rat model. Anesth Analg (2007) 1.08
Electroacupuncture attenuates inflammation in a rat model. J Altern Complement Med (2005) 1.07
Identifying disease genes and module biomarkers by differential interactions. J Am Med Inform Assoc (2011) 1.07
Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol Ther (2011) 1.06
Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues. Cancer Res (2008) 1.04
Differentiation of bone marrow mesenchymal stem cells induced by myocardial medium under hypoxic conditions. Acta Pharmacol Sin (2006) 1.04
The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells. Mol Cell Biol (2008) 1.02
NARROMI: a noise and redundancy reduction technique improves accuracy of gene regulatory network inference. Bioinformatics (2012) 1.01
Parallel assessment of CpG methylation by two-color hybridization with oligonucleotide arrays. Anal Biochem (2002) 1.01
A new pan-nitinol occluder for transcatheter closure of ventricular septal defects in a canine model. J Interv Cardiol (2009) 1.01
Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. PLoS One (2012) 1.01
CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene (2003) 1.00
Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene. Am J Pathol (2004) 1.00
Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract. World J Gastroenterol (2005) 0.99
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. Antimicrob Agents Chemother (2002) 0.98
HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. PLoS One (2008) 0.98
Clinical applications of VEGF-trap (aflibercept) in cancer treatment. J Chin Med Assoc (2010) 0.98
An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment. J Biol Chem (2007) 0.97
Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol Cell Biol (2004) 0.97
Electroacupuncture attenuates bone-cancer-induced hyperalgesia and inhibits spinal preprodynorphin expression in a rat model. Eur J Pain (2008) 0.97
Chloroplast small heat shock protein HSP21 interacts with plastid nucleoid protein pTAC5 and is essential for chloroplast development in Arabidopsis under heat stress. Plant Cell (2013) 0.95
Positive expression of Lin28 is correlated with poor survival in gastric carcinoma. Med Oncol (2013) 0.95
Treatment of landfill leachate using a combined stripping, Fenton, SBR, and coagulation process. J Hazard Mater (2010) 0.94
Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks. Sci Rep (2013) 0.94
Systems biology analysis of Zymomonas mobilis ZM4 ethanol stress responses. PLoS One (2013) 0.94
Prediction of hot spots in protein interfaces using a random forest model with hybrid features. Protein Eng Des Sel (2012) 0.94
Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues. J Steroid Biochem Mol Biol (2008) 0.94
Predicting distant metastasis and chemoresistance using plasma miRNAs. Med Oncol (2013) 0.94
Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics (2011) 0.93
Androgen deprivation and stem cell markers in prostate cancers. Int J Clin Exp Pathol (2009) 0.93
Formal intermolecular [2 + 2] cycloaddition reaction of allenamide [corrected] with alkenes via gold catalysis. Org Lett (2011) 0.92
Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo. Mol Ther (2005) 0.92
Advances in combination of antiangiogenic agents targeting VEGF-binding and conventional chemotherapy and radiation for cancer treatment. J Chin Med Assoc (2010) 0.92
Micro-bending vector sensor based on six-air-hole grapefruit microstructure fiber using lateral offset splicing. Opt Express (2015) 0.91
Systems approaches to modeling chronic mucosal inflammation. Biomed Res Int (2013) 0.91
Histone methylations in heart development, congenital and adult heart diseases. Epigenomics (2015) 0.91
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells. Mol Oncol (2013) 0.91
Systematic identification of transcriptional and post-transcriptional regulations in human respiratory epithelial cells during influenza A virus infection. BMC Bioinformatics (2014) 0.91
Characterizing wetland change at landscape scale in Jiangsu Province, China. Environ Monit Assess (2010) 0.90
Lipofectamine RNAiMAX: an efficient siRNA transfection reagent in human embryonic stem cells. Mol Biotechnol (2008) 0.90
The conserved mitochondrial twin Cx9C protein Cmc2 Is a Cmc1 homologue essential for cytochrome c oxidase biogenesis. J Biol Chem (2010) 0.90
Reversal of the activation sequence along the coronary sinus during RF application with a single left lateral pathway: what is the mechanism? Pacing Clin Electrophysiol (2009) 0.90
Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates. Bioconjug Chem (2013) 0.90
De novo prediction of RNA-protein interactions from sequence information. Mol Biosyst (2012) 0.90
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol (2010) 0.89
Trypsin secretion and turnover in patients with acute pancreatitis. Am J Physiol Gastrointest Liver Physiol (2005) 0.89
Ethyl 3-benzoyl-2-hydroxy-prop-2-enoate. Acta Crystallogr Sect E Struct Rep Online (2007) 0.89
Divergent effects of castration on prostate cancer in TRAMP mice: possible implications for therapy. Clin Cancer Res (2008) 0.89
Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells. Stem Cells (2006) 0.88
Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression. BMC Syst Biol (2011) 0.88
ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression. Mol Endocrinol (2012) 0.87
Tongxinluo promotes mesenchymal stem cell tube formation in vitro. J Zhejiang Univ Sci B (2011) 0.87
A plasmonic based ultracompact polarization beam splitter on silicon-on-insulator waveguides. Sci Rep (2013) 0.87
Recent advances in heat shock protein-based cancer vaccines. Hepatobiliary Pancreat Dis Int (2006) 0.87
Shikonin and its derivatives: a patent review. Expert Opin Ther Pat (2012) 0.86
Gaussian graphical model for identifying significantly responsive regulatory networks from time course high-throughput data. IET Syst Biol (2013) 0.86
Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. J Mol Med (Berl) (2012) 0.86
Structure-activity relationships of 2'-fluoro-2',3'-unsaturated D-nucleosides as anti-HIV-1 agents. J Med Chem (2002) 0.86